Articles published in Journal of Clinical Research & Bioethics have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Research & Bioethics has got h-index 19, which means every article in Journal of Clinical Research & Bioethics has got 19 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical Research & Bioethics.

  2022 2021 2020 2019 2018

Year wise published articles

60 61 52 9 16

Year wise citations received

155 184 182 171 162
Journal total citations count 1808
Journal Impact Factor 1.91
Journal 5 years Impact Factor 2.41
Journal CiteScore 5.23
Journal h-index 19
Important citations

Mallath MK, Chawla T (2017) Investigators' viewpoint of clinical trials in India: Past, present and future. Perspectives in Clinical Research 8: 31.

Tarling TE, Lasser F, Carter C, Matzke LA, Dhugga G et al (2017) Business Planning for a Campus-Wide Biobank. Biopreservation and Biobanking 15: 37-45.

Kong CC, Tarling TE, Strahlendorf C, Dittrick M, Vercauteren SM (2016) Opinions of Adolescents and Parents About Pediatric Biobanking. Journal of Adolescent Health 58: 474-480.

Kheir AE, Dafaalla M, Bashir A, Abuelgasim N, Abdalrahman I (2016) Medicolegal awareness amongst health professionals in Sudan-where are we now?. Online J Clin Audits 8:4.

Musazzi UM, Marini V, Casiraghi A, Minghetti P (2017) Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials?. Drug Discovery Today 9: 11.

Brand R, Wolff W, Ziegler M (2016) Drugs as instruments: describing and testing a behavioral approach to the study of neuroenhancement. Frontiers in psychology 1;7.

Dubljević V, Ryan CJ (2015) Cognitive enhancement with methylphenidate and modafinil: conceptual advances and societal implications. Neurol Neurosci 4: 25-33.

Garasic MD, Lavazza A (2016) Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts. BMC medical ethics 17: 18.

Kusaczuk M, Krętowski R, Stypułkowska A, Cechowska-Pasko M (2016) Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor–belinostat–in glioblastoma cell lines: a preliminary report. Investigational New Drugs 34: 552-564.

KALKAN R (2009) Educaation and Academic Degrees. Cancer.

Steponaitis G, Kazlauskas A, Skiriute D, Valiulyte I, Skauminas K (2016) Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma. Oncology Letters 12: 3305-3311.

Munung NS (2015) African researchers' perceptions and expectations of the benefits of genomics research in Africa: a qualitative study, Doctoral dissertation, University of Cape Town.

Okoro EO (2017) Effective Treatment Matters: Revitalizing Pharmacovigilance. InPharmacovigilance. Springer International Publishing pp. 121-130.

Groisman IJ, Godard B (2016) Impact of Next Generation Sequencing on the Organization and Funding of Returning Research Results: Survey of Canadian Research Ethics Boards Members. PloS one 11: e0154965.

Haqiqi MA, Pourmoshir N, Bereshneh AH (2016) Clinical and Genetic Aspects of Oral Lichen Planus. International J Biomedical Adv Res 7: 251-256.

Dhama N (2015) Stem Cell Research Therapy for Neurodegenerative Disorders - In What Way to Make it Work 4: 2.

Meller R (2015) Addressing Benefits, Risks and Consent in Next Generation Sequencing Studies. J clin Res bioethics 6: 6.

Dhama N (2015) Stem Cell Research Therapy for Neurodegenerative Disorders - In What Way to Make it Work 4: 5

Behnia F, Elojeimy S, Matesan M, Fajgenbaum DC (2016) Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome. Annals of Hematology 16: 1-4.

Gamboa-Bernal GA (2016) LA EDICIÓN DE GENES A ESTUDIO: LOS PROBLEMAS BIOÉTICOS QUE PUEDE TENER ESTA NUEVA TECNOLOGÍA. Persona y Bioética 9; 20.